| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Center for Rheumatology/Bloomsbury Rheumatology Unit, Department of Medicine, University College London, London, United Kingdom
An experimental model of systemic lupus erythematosus has recently been described in normal animals. We sought to confirm and extend this model, which involved immunization of normal rabbits and mice with a peptide of Sm B/B', PPPGMRPP. This peptide is an early target of the immune response in anti-Sm-positive patients with lupus. The peptide was used in a multiple Ag peptide format, with multiple copies of PPPGMRPP bound to an inert lysine backbone. New Zealand White rabbits and A/J and C57BL/10ScSn mouse strains were immunized with PPPGMRPP-MAP. Pepscan assays were used to determine the epitope spreading of the anti-PPPGMRPP-MAP response to other octamers of SmB/B' following immunization. We obtained high titer anti-PPPGMRPP-MAP IgG responses in the New Zealand White rabbits and A/J mice. The rabbits immunized with PPPGMRPP-MAP showed varying degrees of epitope spreading, while the A/J mice showed no spreading. We observed no autoantibodies to dsDNA or other anti-nuclear autoantibodies in our animals by ELISA or immunofluorescence, although anti-nuclear autoantibodies were found by Western blotting in some of the rabbits. No evidence of clinical disease was seen in our normal animals. These data underline the difficulties often associated with the reproduction of animal models in different laboratories.
This article has been cited by other articles:
|
|
 |
|
  M Ishii, Y Muramoto, H Kosaka, S Ohshima, T Mima, Y Katada, S Hirohata, and Y Saeki A serological switching from anti-dsDNA to anti-Sm antibodies coincided with severe clinical manifestations of systemic lupus erythematosus (hemophagocytosis, profundus and psychosis) Lupus, January 1, 2007; 16(1): 67 - 69. [PDF]
|
|
|
|
 |
|
 G. Rai, S. Ray, R. E. Shaw, P. F. DeGrange, R. G. Mage, and B. A. Newman Models of Systemic Lupus Erythematosus: Development of Autoimmunity Following Peptide Immunizations of Noninbred Pedigreed Rabbits J. Immunol., January 1, 2006; 176(1): 660 - 667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Pal, U. S. Deshmukh, Y. Ohyama, Q. Fang, C. C. Kannapell, F. Gaskin, and S. M. Fu Evidence for Multiple Shared Antigenic Determinants within Ro60 and Other Lupus-Related Ribonucleoprotein Autoantigens in Human Autoimmune Responses J. Immunol., December 1, 2005; 175(11): 7669 - 7677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J K Kalsi, J Grossman, J Kim, P Sieling, D W Gjertson, E F Reed, F M Ebling, M Linker-Israeli, and B H Hahn Peptides from antibodies to DNA elicit cytokine release from peripheral blood mononuclear cells of patients with systemic lupus erythematosus: relation of cytokine pattern to disease duration Lupus, July 1, 2004; 13(7): 490 - 500. [Abstract] [PDF]
|
|
|
|
|
|
B H Hahn Lessons in lupus: the mighty mouse Lupus, September 1, 2001; 10(9): 589 - 593. [PDF]
|
|
|
|
|
|
M Lidar, A Braf, N Givol, P Langevitz, R Pauzner, A Many, and A Livneh Anti-insulin antibodies and the natural autoimmune response in systemic lupus erythematosus Lupus, February 1, 2001; 10(2): 81 - 86. [Abstract] [PDF]
|
|
|
|
|
|
M Chang, S E Walker, and R W Hoffman Immunization with a bacterial ATP-binding cassette transporter fragment suppresses autoimmunity and prolongs survival in MRL/lpr lupus-prone mice Lupus, November 1, 2000; 9(9): 655 - 663. [Abstract] [PDF]
|
|
|
|
 |
|
 M. L. Stoll and J. Gavalchin Systemic lupus erythematosus--messages from experimental models Rheumatology, January 1, 2000; 39(1): 18 - 27. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
